However, large scale clinical trials are warranted to support the application of SNS in treating breast cancer patients with MMD, and in-depth investigation is needed to understand the potential molecular mechanisms of Lactobacillus-Indole-CD8+ T signaling in mediating breast cancer progression. Here, CD8A is linked to multiminicore myopathy.